{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:03:38Z","timestamp":1761901418528,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.msard.2019.06.024","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T03:08:30Z","timestamp":1560913710000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)"],"prefix":"10.1016","volume":"35","author":[{"given":"Louis S.","family":"Matza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie D.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Delio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Naismith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2019.06.024_bib0001","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000334394","article-title":"Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis","volume":"67","author":"Allali","year":"2012","journal-title":"Eur. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2019.06.024_bib0002","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archneur.1988.00520310052017","article-title":"Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis","volume":"45","author":"Amato","year":"1988","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2019.06.024_bib0003","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/135245859900500404","article-title":"Quantification of impairment in MS: discussion of the scales in use","volume":"5","author":"Amato","year":"1999","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2019.06.024_bib0004","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/1352458517721357","article-title":"Streamlined EDSS for use in multiple sclerosis clinical practice: development and cross-sectional comparison to EDSS","volume":"24","author":"Baldassari","year":"2018","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.msard.2019.06.024_bib0005","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s11136-012-0334-0","article-title":"Validation of a new quality of life scale related to multiple sclerosis and relapses","volume":"22","author":"Baroin","year":"2013","journal-title":"Qual. Life Res."},{"issue":"8","key":"10.1016\/j.msard.2019.06.024_bib0006","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.55.8.671","article-title":"EDMUS, a European database for multiple sclerosis","volume":"55","author":"Confavreux","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 5","key":"10.1016\/j.msard.2019.06.024_bib0007","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/brain\/122.5.871","article-title":"Development of a multiple sclerosis functional composite as a clinical trial outcome measure","volume":"122","author":"Cutter","year":"1999","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.msard.2019.06.024_bib0008","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/1352458509106513","article-title":"The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)","volume":"15","author":"Doward","year":"2009","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2019.06.024_bib0009","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/135245859900500410","article-title":"Recent developments in the assessment of quality of life in multiple sclerosis (MS)","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2019.06.024_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/135245859900500409","article-title":"The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS society clinical outcomes assessment task force","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult Scler."},{"issue":"235","key":"10.1016\/j.msard.2019.06.024_bib0011","first-page":"65132","article-title":"Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims","volume":"74","year":"2009","journal-title":"Fed. Regist."},{"issue":"3","key":"10.1016\/j.msard.2019.06.024_bib0012","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1352458511420598","article-title":"Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set","volume":"18","author":"Gijbels","year":"2012","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2019.06.024_bib0013","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/WNL.42.4.859","article-title":"Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group","volume":"42","author":"Goodkin","year":"1992","journal-title":"Neurology."},{"issue":"Pt 5","key":"10.1016\/j.msard.2019.06.024_bib0014","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/brain\/123.5.1027","article-title":"Kurtzke scales revisited: the application of psychometric methods to clinical intuition","volume":"123","author":"Hobart","year":"2000","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.msard.2019.06.024_bib0015","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/brain\/124.5.962","article-title":"The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure","volume":"124","author":"Hobart","year":"2001","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.msard.2019.06.024_bib0016","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/brain\/awh675","article-title":"Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)","volume":"129","author":"Hobart","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2019.06.024_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.45.2.251","article-title":"Disease steps in multiple sclerosis: a simple approach to evaluate disease progression","volume":"45","author":"Hohol","year":"1995","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.msard.2019.06.024_bib0018","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2019.06.024_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000136645","article-title":"Historical and clinical perspectives of the expanded disability status scale","volume":"31","author":"Kurtzke","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2019.06.024_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7525-8-22","article-title":"Development of a patient reported outcome scale for fatigue in multiple sclerosis: the Neurological Fatigue Index (NFI-MS)","volume":"8","author":"Mills","year":"2010","journal-title":"Health Qual. Life Outcomes"},{"year":"2011","series-title":"Multiple Sclerosis Information for Health and Social Care Professionals: Clinical Measures","key":"10.1016\/j.msard.2019.06.024_bib0021"},{"issue":"8","key":"10.1016\/j.msard.2019.06.024_bib0022","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2013eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.msard.2019.06.024_bib0023","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2\u2013assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.msard.2019.06.024_bib0024","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \"Up & Go\": a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.msard.2019.06.024_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jval.2016.11.005","article-title":"Clinician-reported outcome assessments of treatment benefit: report of the ISPOR clinical outcome assessment emerging good practices task force","volume":"20","author":"Powers","year":"2017","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.msard.2019.06.024_bib0026","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","article-title":"Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report","volume":"12","author":"Rothman","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.msard.2019.06.024_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/WNL.52.1.63","article-title":"Reliability and validity of two self-report measures of impairment and disability for MS. North American research consortium on multiple sclerosis outcomes study group","volume":"52","author":"Schwartz","year":"1999","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.msard.2019.06.024_bib0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/135245859900500406","article-title":"The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis","volume":"5","author":"Sharrack","year":"1999","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2019.06.024_bib0029","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1212\/WNL.34.10.1368","article-title":"A neurologic rating scale (NRS) for use in multiple sclerosis","volume":"34","author":"Sipe","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2019.06.024_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40263-017-0412-5","article-title":"Outcome measures in clinical trials for multiple sclerosis","volume":"31","author":"van Munster","year":"2017","journal-title":"CNS Drugs"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819302706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819302706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:45:03Z","timestamp":1761900303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819302706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"alternative-id":["S2211034819302706"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.06.024","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}